Internal Medicine, Hematology & Oncology · Portland, OR
NPI
1750813101
Since 2017
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
3600 N Interstate Ave
Portland, OR, 97227
Phone (800) 813-2000
Groups this clinician bills Medicare through
Medicare paid, 2024
$44K
1,484 services
Medicare patients, 2024
24
Average age 69
Drug cost, 2024
$5.5M
2,401 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Ashray Maniar prescribed most often to Medicare patients was Prednisone, with 296 prescriptions and refills. In total Ashray Maniar wrote 2,401 Medicare prescriptions that cost $5.5M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-03-12.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Prednisone Generic | 296 | 515 | 81 | $2,373 |
| Abiraterone Acetate Generic | 263 | 451 | 55 | $63K |
| Anastrozole Generic | 206 | 598 | 79 | $5,618 |
| Dexamethasone Generic | 143 | 149 | 63 | $1,460 |
| Prochlorperazine Maleate Generic | 123 | 123 | 68 | $1,558 |
| Ondansetron Hcl Generic | 95 | 99 | 60 | $765 |
| Potassium Chloride Generic | 90 | 215 | 37 | $2,093 |
| Tamoxifen Citrate Generic | 86 | 239 | 32 | $1,686 |
| Tagrisso Osimertinib Mesylate | 83 | 83 | 14 | $1.5M |
| Olanzapine Generic | 74 | 93 | 48 | $468 |
| Levothyroxine Sodium Generic | 58 | 171 | 16 | $1,070 |
| Letrozole Generic | 56 | 136 | 26 | $1,002 |
| Oxycodone Hcl Generic | 54 | 54 | 29 | $1,116 |
| Retevmo Selpercatinib | 48 | 48 | Under 11 | $932K |
| Gabapentin Generic | 45 | 64 | 11 | $730 |
Brand drugs: 389 claims; generic drugs: 2,012 claims; opioid claims: 71.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Ashray Maniar were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.